Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vaccines

Free Subscription 21.10.2019 1 BMJ 6 Clin Infect Dis 7 J Infect Dis 1 JAMA 2 Lancet Glob Health 2 Lancet HIV 4 MMWR Morb Mortal Wkly Rep 1 Pediatrics 4 PLoS One 15 Vaccine 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMJ

1. MAHASE E
   Mandatory childhood vaccination could cause "irreparable damage," says expert panel.
   BMJ. 2019;367:l5995.
   PubMed     Text format    
   
   

   
   Clin Infect Dis

2. CAREY ME, Diaz ZI, Broadstock M, Bailey R, et al
   Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction.
   Clin Infect Dis. 2019;69.
   PubMed     Text format     Abstract available
   
   
3. MEIRING JE, Giubilini A, Savulescu J, Pitzer VE, et al
   Generating the Evidence for Typhoid Vaccine Introduction: Considerations for Global Disease Burden Estimates and Vaccine Testing Through Human Challenge.
   Clin Infect Dis. 2019;69.
   PubMed     Text format     Abstract available
   
   
4. DONKEN R, Dobson SRM, Marty KD, Cook D, et al
   Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.
   Clin Infect Dis. 2019 Sep 6. pii: 5564371. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
5. LEVIN MJ, Weinberg A
   Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine.
   Clin Infect Dis. 2019 Oct 16. pii: 5588657. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
6. GOMES-SOLECKI M, Arnaboldi PM, Backenson PB, Benach JL, et al
   Protective Immunity and New Vaccines for Lyme Disease.
   Clin Infect Dis. 2019 Oct 17. pii: 5588349. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
7. HEALY SA, Murphy SC, Hume JCC, Shelton L, et al
   Chemoprophylaxis vaccination: Phase 1 study to explore stage-specific immunity to Plasmodium falciparum in U.S. adults.
   Clin Infect Dis. 2019 Oct 17. pii: 5588862. doi: 10.1093/cid/ciz1010.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

8. FRIES L, Cho I, Krahling V, Fehling SK, et al
   A Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein (EBOV GP) Nanoparticle Vaccine with Matrix-M Adjuvant in Healthy Adults.
   J Infect Dis. 2019 Oct 11. pii: 5585635. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
9. BAUSCH DG, Piot P
   Ebola Vaccines: Biomedical Advances, Human Rights Challenges.
   J Infect Dis. 2019 Oct 11. pii: 5585661. doi: 10.1093.
   PubMed     Text format    
   
   
10. KARRON RA, Luongo C, Mateo JS, Wanionek K, et al
    Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/DeltaNS2/Delta1313/I1314L in RSV-Seronegative Children.
    J Infect Dis. 2019 Oct 12. pii: 5586371. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
11. BARTLETT S, Eichenberger RM, Nevagi RJ, Ghaffar KA, et al
    Lipopeptide-based oral vaccine against hookworm infection.
    J Infect Dis. 2019 Oct 17. pii: 5588831. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
12. LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
    Erratum to: Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged >/=65 Years.
    J Infect Dis. 2019 Oct 17. pii: 5588808. doi: 10.1093.
    PubMed     Text format    
    
    
13. KILAPANDAL VENKATRAMAN SM, Sivanandham R, Pandrea I, Apetrei C, et al
    BCG Vaccination and Mother-to-Infant Transmission of HIV.
    J Infect Dis. 2019 Oct 12. pii: 5586559. doi: 10.1093.
    PubMed     Text format    
    
    
14. WOOD MP, Wood LF, Templeton M, Fisher B, et al
    Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection.
    J Infect Dis. 2019 Oct 12. pii: 5586557. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

15. MEISSNER HC
    Complexity in Assessing the Benefit vs Risk of Vaccines: Experience With Rotavirus and Dengue Virus Vaccines.
    JAMA. 2019 Oct 17. pii: 2753531. doi: 10.1001/jama.2019.16206.
    PubMed     Text format    
    
    

    
    Lancet Glob Health

16. CLARK A, Tate J, Parashar U, Jit M, et al
    Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
    Lancet Glob Health. 2019;7:e1541-e1552.
    PubMed     Text format     Abstract available
    
    
17. KANG G
    Improving the performance of oral rotavirus vaccines.
    Lancet Glob Health. 2019;7:e1472-e1473.
    PubMed     Text format    
    
    

    
    Lancet HIV

18. PANTALEO G, Janes H, Karuna S, Grant S, et al
    Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial.
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30262.
    PubMed     Text format     Abstract available
    
    
19. FELBER BK, Pavlakis GN
    HIV vaccine: better to start together?
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30323.
    PubMed     Text format    
    
    

    
    MMWR Morb Mortal Wkly Rep

20. PATEL M, Lee AD, Clemmons NS, Redd SB, et al
    National Update on Measles Cases and Outbreaks - United States, January 1-October 1, 2019.
    MMWR Morb Mortal Wkly Rep. 2019;68:893-896.
    PubMed     Text format     Abstract available
    
    
21. LINDLEY MC, Kahn KE, Bardenheier BH, D'Angelo DV, et al
    Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants - United States.
    MMWR Morb Mortal Wkly Rep. 2019;68:885-892.
    PubMed     Text format     Abstract available
    
    
22. SEITHER R, Loretan C, Driver K, Mellerson JL, et al
    Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2018-19 School Year.
    MMWR Morb Mortal Wkly Rep. 2019;68:905-912.
    PubMed     Text format     Abstract available
    
    
23. HILL HA, Singleton JA, Yankey D, Elam-Evans LD, et al
    Vaccination Coverage by Age 24 Months Among Children Born in 2015 and 2016 - National Immunization Survey-Child, United States, 2016-2018.
    MMWR Morb Mortal Wkly Rep. 2019;68:913-918.
    PubMed     Text format     Abstract available
    
    

    
    Pediatrics

24. DEMPSEY AF
    Three Important Findings From a Study on HPV "Real World" Effectiveness.
    Pediatrics. 2019;143.
    PubMed     Text format    
    
    

    
    PLoS One

25. WU CY, Yu SL, Chen YT, Chen YH, et al
    The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus.
    PLoS One. 2019;14:e0210553.
    PubMed     Text format     Abstract available
    
    
26. MARTINEZ-VEGA R, Jauneikaite E, Thoon KC, Chua HY, et al
    Risk factor profiles and clinical outcomes for children and adults with pneumococcal infections in Singapore: A need to expand vaccination policy?
    PLoS One. 2019;14:e0220951.
    PubMed     Text format     Abstract available
    
    
27. STAUFT CB, Yang C, Coleman JR, Boltz D, et al
    Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets.
    PLoS One. 2019;14:e0223784.
    PubMed     Text format     Abstract available
    
    
28. BRADHURST R, Garner G, East I, Death C, et al
    Management strategies for vaccinated animals after an outbreak of foot-and-mouth disease and the impact on return to trade.
    PLoS One. 2019;14:e0223518.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

29. VAN AALST R, Gravenstein S, Mor V, Mahmud SM, et al
    Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study.
    Vaccine. 2019 Oct 9. pii: S0264-410X(19)31349.
    PubMed     Text format     Abstract available
    
    
30. TAVOSCHI L, Quattrone F, De Vita E, Lopalco PL, et al
    Impact of mandatory law on vaccine hesitancy spectrum: The case of measles vaccine catch-up activities in Tuscany, Italy.
    Vaccine. 2019 Oct 9. pii: S0264-410X(19)31334.
    PubMed     Text format    
    
    
31. WOLFF GG
    Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31364.
    PubMed     Text format     Abstract available
    
    
32. CONSTENLA D, Liu T
    Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31326.
    PubMed     Text format     Abstract available
    
    
33. LIU Z, Behloul N, Baha S, Wei W, et al
    Design and immunogenicity analysis of the combined vaccine against zoonotic hepatitis E and foot-and-mouth disease.
    Vaccine. 2019 Oct 8. pii: S0264-410X(19)31245.
    PubMed     Text format     Abstract available
    
    
34. BALL C, Forrester A, Herrmann A, Lemiere S, et al
    Comparative protective immunity provided by live vaccines of Newcastle disease virus or avian metapneumovirus when co-administered alongside classical and variant strains of infectious bronchitis virus in day-old broiler chicks.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31323.
    PubMed     Text format     Abstract available
    
    
35. SATO R
    Differential determinants and reasons for the non- and partial vaccination of children among Nigerian caregivers.
    Vaccine. 2019 Oct 12. pii: S0264-410X(19)31341.
    PubMed     Text format     Abstract available
    
    
36. SUZUKI M, Morimoto K
    Pneumonia endpoints must be standardized for adult pneumococcal vaccine trials.
    Vaccine. 2019 Oct 12. pii: S0264-410X(19)31376.
    PubMed     Text format    
    
    
37. SHAHBARI NAE, Gesser-Edelsburg A, Mesch GS
    Perceived trust in the health system among mothers and nurses and its relationship to the issue of vaccinations among the Arab population of Israel: A qualitative research study.
    Vaccine. 2019 Oct 11. pii: S0264-410X(19)31340.
    PubMed     Text format     Abstract available
    
    
38. SAADEH K, Park I, Gargano JW, Whitney E, et al
    Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States.
    Vaccine. 2019 Oct 11. pii: S0264-410X(19)31347.
    PubMed     Text format     Abstract available
    
    
39. BERNSTEIN DI, Morello CS, Cardin RD, Bravo FJ, et al
    A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2.
    Vaccine. 2019 Oct 11. pii: S0264-410X(19)31332.
    PubMed     Text format     Abstract available
    
    
40. GARG H, Mehmetoglu-Gurbuz T, Ruddy GM, Joshi A, et al
    Capsid containing virus like particle vaccine against Zika virus made from a stable cell line.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31335.
    PubMed     Text format     Abstract available
    
    
41. COWLEY D, Sari RM, Handley A, Watts E, et al
    Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31299.
    PubMed     Text format     Abstract available
    
    
42. LEE B, Dickson DM, Alam M, Afreen S, et al
    The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31330.
    PubMed     Text format     Abstract available
    
    
43. ROBERTS NJ JR
    Respiratory syncytial virus suppression of the antiviral immune response: Implications for evaluation of candidate vaccines.
    Vaccine. 2019 Oct 10. pii: S0264-410X(19)31339.
    PubMed     Text format     Abstract available
    
    

    
    Virus Res

44. KAMEL M, El-Sayed A
    Toward peste des petits virus (PPRV) eradication: diagnostic approaches, novel vaccines, and control strategies.
    Virus Res. 2019 Oct 10:197774. doi: 10.1016/j.virusres.2019.197774.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: